The Global Ventricular Assist Devices Market Growth Accelerated By Technological Advancements
Ventricular Assist Devices Market |
Ventricular assist devices are mechanical pumps used to support heart function and blood flow in patients with weak or failing hearts. These devices have advantages over traditional heart pumps as they are more reliable, energy efficient and offer portability. The rising prevalence of cardiovascular diseases and growing number of transplant procedures have increased the demand for ventricular assist devices.
The global Ventricular Assist Devices Market is
estimated to be valued at US$ 1.37 Bn
in 2023 and is expected to exhibit a
CAGR of 5.3% over the forecast period 2023 to 2030, as
highlighted in a new report published by Coherent Market Insights.
Market key trends:
Technological advancements is one of the key trends driving the growth of the
ventricular assist devices market. Manufacturers are increasingly investing in
research and development to develop next-generation devices with improved
features. For instance, devices are being miniaturized to increase patient
mobility and made wireless to eliminate driveline infections. Second generation
devices with improved durability are also gaining popularity. Moreover, third
generation continuous flow devices that mimic the physiology of the native
heart are in the pipeline. Such innovative devices are expected to
significantly boost the adoption of ventricular assist devices during the
forecast period.
Segment Analysis
The ventricular assist devices market is divided into two dominant segments
namely, left ventricular assist devices (LVAD) and right ventricular assist
devices (RVAD). The LVAD segment holds the largest market share currently due
to the high prevalence of left ventricular failure. LVAD provides long-term
support of heart function for those suffering from advanced heart failure.
Key Takeaways
The global Ventricular
Assist Devices Market Growth is expected to witness high growth over
the forecast period of 2023 to 2030. The global Ventricular Assist Devices
Market is estimated to be valued at US$ 1.37 Bn in 2023 and is expected to exhibit a CAGR of 5.3% over the
forecast period 2023 to 2030.
Regional analysis: North America currently dominates the ventricular assist
devices market and is expected to continue its dominance over the forecast
period. This is attributed to advanced healthcare infrastructure and rising
government funding for heart failure treatment in the region. Europe is
expected to be the second largest market driven by increasing research on
ventricular assist devices and presence of key market players.
Key players: Key players operating in the ventricular assist devices market are
Abbott Laboratories , Abiomed , Berlin Heart GmbH, CardiacAssist , Jarvik Heart
, Medtronic , ReliantHeart, SynCardia Systems , and Terumo Corporation. Abbott
Laboratories holds the largest market share currently due to its wide portfolio
of ventricular assist devices including HeartMate 3 left ventricular assist
device.
Explore more
related article on this topic: https://www.ukwebwire.com/the-demand-for-ventricular-assist-devices-demand/
Comments
Post a Comment